Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elif Birtas Atesoglu

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 14, 2016
Isolated Breast Relapse of Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationEsra Terzi Demirsoy, Elif Birtas Atesoglu, Pinar Tarkun, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2014
Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP ImmunopathogenesisElif Birtas Atesoglu, Pinar Tarkun, Esra Terzi Demirsoy, et al.
European Journal of Haematology|September 16, 2014
Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?Pinar Tarkun, Figen Atalay, Elif Birtas Atesoglu, et al.
Hematological Oncology|May 22, 2023
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world dataElif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, et al.
Hematological Oncology|June 25, 2021
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective studyOlga Meltem Akay, Murat Ozbalak, Mustafa Pehlivan, et al.
Journal of Clinical Medicine|October 16, 2025
Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study GroupEmel Isleyen, Nurcan Alhan, Esra Terzi Demirsoy, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 14, 2016
Isolated Breast Relapse of Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationEsra Terzi Demirsoy, Elif Birtas Atesoglu, Pinar Tarkun, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2014
Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP ImmunopathogenesisElif Birtas Atesoglu, Pinar Tarkun, Esra Terzi Demirsoy, et al.
European Journal of Haematology|September 16, 2014
Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?Pinar Tarkun, Figen Atalay, Elif Birtas Atesoglu, et al.
Hematological Oncology|May 22, 2023
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world dataElif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, et al.
Hematological Oncology|June 25, 2021
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective studyOlga Meltem Akay, Murat Ozbalak, Mustafa Pehlivan, et al.
Journal of Clinical Medicine|October 16, 2025
Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study GroupEmel Isleyen, Nurcan Alhan, Esra Terzi Demirsoy, et al.
Pageof 2